PLAC Facts

The PLAC® Test is the only blood test cleared by the FDA to aid in assessing risk for both coronary heart disease and ischemic stroke associated with atherosclerosis. 87% of strokes are ischemic1.

68% of all heart attacks and strokes occur from clots, not from narrowing of the arteries.

Press Releases

July 28, 2010
VaxGen and diaDexus Complete Merger

May 19, 2010
Large Meta-Analysis Further Validates Benefit of Measuring Lp-PLA2 for Coronary Heart Disease and Ischemic Stroke Risk Assessment

June 16, 2009
diaDexus Announces Data on Lp-PLA2 To Be Presented at International Symposium on Atherosclerosis

December 18, 2008
Study published in stroke finds testing for Lp-PLA2 and hs-CRP more accurately identifies individuals at risk of suffering a stroke.

December 17, 2008
Living Heart Foundation and the PLAC Test for Lp-PLA2 are featured on NPR's Only a Game

December 1, 2008
diaDexus Receives CE Mark Certification for the PLAC® Test

September 28, 2008
diaDexus, Inc. and Living Heart Foundation Offer The PLAC® Test to Detect Hidden Risk for Heart Attack and Stroke in Retired NFL Players

September 15, 2008
Mark Alberts, M.D., answers a QualityHealth reader's question about additional measures he can take to reduce his risk of suffering from a heart attack.

August 27, 2008
diaDexus, Inc. announces the appointment of Physicians Sales & Service, Inc. (PSS) as distributors of the PLAC Test to physician office laboratories in the United States.

July 25, 2008
The PLAC Test for Lp-PLA2 is featured on KOMO 4 TV's Northwest Afternoon with guest Dr. Sarah Speck, M.D, Swedish Medical Center chief of cardiology.

June 17, 2008
Expert Consensus Panel Recommendation for Incorporating Lp-PLA2 Testing into Cardiovascular Disease Risk Assessment Guidelines

April 15, 2008
diaDexus Selects Fisher HealthCare to Sell New Automated PLAC® Test

February 19, 2008
diaDexus Receives FDA Clearance For Automated Blood Test That Identifies Stroke & Heart Attack Risk

July 6, 2007
ARIC study indicates PLAC Test can assess risk of stroke

July 5, 2007
Study Shows Lp-PLA2 Identifies Individuals at Highest Risk for Ischemic Stroke

May 30, 2007
diaDexus Announces Additional U.S. Patent For Lp-PLA2 Activity-Based Atherosclerosis Diagnostic Test

March 26, 2007
Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2 Predicts Heart Disease Risk in Metabolic Syndrome Patients

January 2, 2007
diaDexus to Present at JPMorgan’s 25th Annual Healthcare Conference